Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Non-Coding RNA|February 24, 2023
Non-Coding RNA-Dependent Regulation of Mitochondrial Dynamics in Cancer PathophysiologyMaria Eugenia Gallo Cantafio, Roberta Torcasio, Giuseppe Viglietto, et al.
Clinical and Experimental Medicine|August 28, 2023
Lipid metabolic vulnerabilities of multiple myelomaRoberta Torcasio, Maria Eugenia Gallo Cantafio, Raissa Kaori Ikeda, et al.
Cancers|February 11, 2023
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma CellsRita Casadonte, Jörg Kriegsmann, Mark Kriegsmann, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|December 8, 2025
Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistanceTeresa Rossi, Roberta Torcasio, Ludovica Ganino, et al.
Molecules (Basel, Switzerland)|February 11, 2023
Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple MyelomaFrancesca Alessandra Ambrosio, Giosuè Costa, Maria Eugenia Gallo Cantafio, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
New Insights for Polyphenolic Compounds as Naturally Inspired Proteasome InhibitorsEmanuela Marchese, Maria Eugenia Gallo Cantafio, Francesca Alessandra Ambrosio, et al.
Cells|September 28, 2023
GPER1 Activation Exerts Anti-Tumor Activity in Multiple MyelomaMaria Eugenia Gallo Cantafio, Roberta Torcasio, Francesca Scionti, et al.
Antioxidants (Basel, Switzerland)|May 27, 2023
Uncovering Novel Capsaicin Inhibitory Activity towards Human Carbonic Anhydrase Isoforms IX and XII by Combining In Silico and In Vitro StudiesGianmarco Gualtieri, Annalisa Maruca, Roberta Rocca, et al.
Journal of Translational Medicine|August 15, 2025
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclaxIlenia Valentino, Maria Eugenia Gallo Cantafio, Roberta Torcasio, et al.
Molecular Biology Reports|September 18, 2025
Cytogenetic and molecular characterization of an atypical ETP-ALL case with BCL2 dependency: therapeutic implications for Venetoclax useFrancesco Gigliotti, Carolina Brescia, Salvatore Audia, et al.
Pageof 2